Completed NA INTERVENTIONAL 2-arm NCT04572789

Omega-3 Fatty Acid in the Prevention of Migraine

Omega-3 Fatty Acid in the Prevention of Migraine: From the Randomized Clinical Trial to Molecular Biology Approaches

Sponsor: Kuang Tien General Hospital

Conditions Migraine Omega-3 Polyunsaturated Fatty Acids

Interventions Omega-3 polyunsaturated fatty acids omega-6 PUFAs

Updated 9 times since 2020 Last updated: Jun 22, 2022 Started: Dec 3, 2020 Primary completion: Mar 31, 2022 Completion: Mar 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Migraine and Omega-3 Polyunsaturated Fatty Acids and is currently completed. Kuang Tien General Hospital leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jul 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Nov 2021 — Jul 2022 [monthly]

Recruiting NA
Oct 2021 — Nov 2021 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Mar 2021 — Oct 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2021 — Mar 2021 [monthly]

Not Yet Recruiting NA
Nov 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA
Oct 2020 — Nov 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kuang Tien General Hospital

Data source: Kuang Tien General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taichung, Taiwan